Vision SCS F2 - 10%+ Owner at Cullinan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
10%+ Owner
Issuer Symbol
CGEM on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Vision SCS F2 since 13 Feb 2025

Holdings reported by Vision SCS F2 for Cullinan Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,255,963 $15,649,299 $12.46 04 Aug 2022 Direct
Common Stock 1,136,525 $14,161,102 $12.46 02 Aug 2022 By Globeways Holdings Ltd.
Common Stock 622,175 $7,752,301 $12.46 02 Aug 2022 By F2-TPO Investments, LLC
Common Stock 537,392 $6,695,904 $12.46 02 Aug 2022 By F2 Bioscience I 2017 Ltd.
Common Stock 325,333 $4,053,649 $12.46 02 Aug 2022 By F2 MG Ltd.
Common Stock 214,798 $2,676,383 $12.46 02 Aug 2022 By F2 MC, LLC
Common Stock 207,803 $2,589,225 $12.46 02 Aug 2022 By Morana Jovan-Embiricos
Common Stock 104,762 $1,305,335 $12.46 02 Aug 2022 By F2 GC, LLC
Common Stock 71,599 $892,124 $12.46 02 Aug 2022 By F2 Bio TD, LLC

Transactions reported by Vision SCS F2 for Cullinan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.